Screening and Quantitative Monitoring of Calreticulin (CALR) Type-2 Positive Patients with Myelofibrosis Following Allogeneic Stem Cell Transplantation using a novel Digital-PCR Assay

被引：0
|
作者：
Kroeger, N. [1 ]
Badbaran, A. [1 ]
Christopeit, M. [1 ]
Wolschke, C. [1 ]
Ayuk, F. [1 ]
Aranyossy, T. [1 ]
Fehse, B. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O146
引用
收藏
页码：S85 / S86
页数：2
相关论文
共 50 条
  • [1] Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
    Badbaran, A.
    Fehse, B.
    Christopeit, M.
    Aranyossy, T.
    Ayuk, F. A.
    Wolschke, C.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 (06) : 872 - 873
  • [2] Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
    A Badbaran
    B Fehse
    M Christopeit
    T Aranyossy
    F A Ayuk
    C Wolschke
    N Kröger
    Bone Marrow Transplantation, 2016, 51 : 872 - 873
  • [3] Development of a Digital-PCR Assay for Screening and Quantitative Monitoring of Calreticulin (CALR) Type-2 Positive Patients with Myelofibrosis Following Allogeneic Stem Cell Transplantation
    Fehse, Boris
    Badbaran, Anita
    Christopeit, Maximilian
    Aranyossy, Tim
    Ayuk, Francis
    Wolschke, Christine
    Kroeger, Nicolaus
    BLOOD, 2015, 126 (23)
  • [4] Monitoring of Calreticulin mutations and hematopoietic chimerism by digital PCR after allogeneic stem cell transplantation in patients with myelofibrosis
    Badbaran, A.
    Fehse, B.
    Abd Kadi, S. S. S.
    Christopeit, M.
    Aranyossy, T.
    Ayuk, F.
    Wolschke, C.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 141 - 142
  • [5] Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Christopeit, M.
    Badbaran, A.
    Zabelina, T.
    Zeck, G.
    Fehse, B.
    Ayuk, F.
    Wolschke, C.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 (10) : 1391 - 1393
  • [6] Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
    M Christopeit
    A Badbaran
    T Zabelina
    G Zeck
    B Fehse
    F Ayuk
    C Wolschke
    N Kröger
    Bone Marrow Transplantation, 2016, 51 : 1391 - 1393
  • [7] Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Christopeit, M.
    Badbaran, A.
    Zabelina, T.
    Zeck, G.
    Ayuk, F.
    Wolschke, C.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S496 - S496
  • [8] OUTCOME OF JAK2/MPL/CALR TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Panagiota, V.
    Thol, F.
    Markus, B.
    Fehse, B.
    Alchalby, H.
    Badbaran, A.
    Lehmann, U.
    Koenecke, C.
    Shahswar, R.
    Chaturvedi, A.
    Stadler, M.
    Eder, M.
    Goehring, G.
    Koenigsmann, M.
    Kloos, A.
    Trummer, A.
    Schlegelberger, B.
    Kreipe, H. H.
    Ganser, A.
    Kroeger, N.
    Heuser, M.
    HAEMATOLOGICA, 2014, 99 : 127 - 127
  • [9] Digital-droplet PCR for quantitative monitoring of IDH1, IDH2 and DNMT3A mutations after allogeneic stem cell transplantation in patients with myelofibrosis
    Badbaran, A.
    Mannina, D.
    Fehse, B.
    Christopeit, M.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 205 - 205
  • [10] Comparison of quantitative CMV-PCR in plasma and CMV antigenaemia assay in monitoring patients after allogeneic stem cell transplantation
    Picardi, A
    Gentile, G
    de Fabritiis, P
    Capobianchi, A
    Cudillo, L
    Dentamaro, T
    Tendas, A
    Cupelli, L
    Ciotti, M
    Volpi, A
    Amadori, S
    Martino, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S198 - S198
12345